Immune disorders Flashcards
Immune Reactions
Immune system has numerous functions including
Prevention/defense from infection
Inactivation and clearance of foreign substances
Immune reactions can cause host tissue injury
Hypersensitivity reactions cause release of inflammatory mediators that lead to tissue damage and eventually can lead to scarring (repair)
Hypersensitivity Reactions
Type I – Immediate (anaphylactic)
Mediated by TH2 cell cytokines
Via IL-4 action on B cells get class switching to IgE
Via IL-5 get development and activation of eosinophils
Type II – Antibody-mediated
Secreted ***IgG and IgM antibodies participate directly in injury to cells
Type III – Immune complex mediated
IgG and IgM antibodies bind antigens and the antigen-antibody complexes deposit in tissues and induce inflammation
Type IV – Cell mediated
Sensitized T-lymphocytes (TH1, TH17 cells and CTLs)
hypersensitivity and granuloma
Type IV hypersensitivity
Type I Hypersensitivity Disorders
Anaphylaxis
Hypotension secondary to vasodilation that may lead to shock
Laryngeal edema that may lead to airway obstruction
Inflammation and tissue destruction leading to scarring
Asthma
Reversible bronchoconstriction
Mucous hyperplasia
Inflammation and tissue destruction leading to scarring
Urticaria
Dermal angioedema with wheals
Itching
Food allergies
Increased intestinal peristalsis
Inflammation and tissue destruction leading to scarring
Allergic rhinitis and sinusitis
Mucous hyperplasia
Inflammation and tissue destruction leading to scarring
Type I Immediate Hypersensitivity
Immediate phase: *** 5 to 30 minutes post exposure
for about an hour
Dilated leaky vessels –> edema
Contraction of smooth muscle
Increased mucus production
Late phase: **2 to 24 hours later and may lasts days
Inflammation with eosinophilia–> tissue injury
petechiae and echymoses, what do you start to think?
platelets and/or von Willebrandt’s
granulomas associated with?
Type IV- cell mediated hypersensitivity (activated T lymphocytes)
Type II hypersensitivity
Type II- antibody mediated. IgG or IgM binding
good pasture syndrome
Mechanisms of type I hypersensitivity
Early - TH2 activation IgE class switch in B cells IgE release of mediators from mast cells
Later - TH2, epithelial and mast cells secrete IL-5 and eotaxin → eosinophils → enzyme (major basic protein and cationic protein) release → tissue destruction
signs/ symptoms of anaphylaxis
lightheadedness SOB, stridor skin-- hives, itchiness, flushing Heart-- fast or slow, low blood pressure swelling of lips, tongue and/or throat
Mast cell secretagogues
IgE (via Fc receptors), Anaphylatoxins C5a, C4a and C3a –> Mast cell –> Eosinophil chemotactic factor
among many other things
Urticaria
dermal hyperpermeability & wheals
angioedema
edema of dermis, mucosae and deeper tissues
hereditary angioedema
autosomal dominant C1 inhibitor deficiency
asthma
reversible airway obstruction
autoimmunity
reactions against an individual’s own tissues and cells
types 2,3, and/or 4
Placental transfer in autoimmune disorders
Maternal igG antibodies
thyroid hormone receptor –> graves
RBCs–> hemolytic anemia
platelets–> thrombocytopenia
acetylcholine receptor–> myasthenia gravis
Ro & La–> Cutaneous lupus & heart block
HLA alleles and the diseases
Rheumatoid arthritis- DR4 Type 1 diabetes DR3/DR4 Ankylosing spondylitis- B27 Postgonococcal arthritis-- B27 Autoimmune hepatitis- DR3 Primary Sjogren syndrome- DR3
Non-HLA genes associated with autoimmune diseases
PTPN22– protein tyrosine phosphatase
May affect signaling in lymphocytes
may alter activation of self-reactive T cells
Types II/III Antibody Mediated Hypersensitivity
Antibody-dependent complement-mediated cytotoxicity (Type II)
Classical complement cascade activation leads to lysis of cells
Direct lysis via membrane attack complex (C5b - C9), punches holes in cell
Mechanism normally used for killing Neisseria spp. bacteria
Antibody-dependent cell-mediated cytotoxicity (Type II)
Binding of antibody leads to activation of macrophages, neutrophils, eosinophils, natural killer cells, etc. that lead to cell injury and death
Mechanism normally used for killing other microorganisms, etc
Antibody-dependent cellular dysfunction (Type II)
Antibody binding causes abnormal cellular function (e.g. Graves disease)
No normal use for this mechanism
Antigen-antibody complex mediated attack on host tissues (Type III)
Antigen-antibodies complexes deposit or are initiated in tissue
Complement is activated (C5a attracts infl. Cells, C3a and C5a cause local vasodilation, etc.)
No normal use for this mechanism
Mechanisms of Antibody-mediated Injury
Antibody-dependent complement-mediated cytotoxicity
e.g. ABO incompatibility
Antibody-dependent cell-mediated cytotoxicity
e.g. killing virally infected cell
Autoimmune hemolytic anemia - mechanism
opsonization and phagocytosis of red cells
direct hemolysis via complement with ABO mismatch
Immunologic Thrombocytopenic Purpura
Spleen: normal size, congested sinusoids, prominent germinal centers, occasional megakaryocytes
Marrow: increased megakaryocytes
Peripheral blood: megathrombocytes
Goodpasture Syndrome
Diagnose = linear fluorescence
Antigen hidden in type collagen IV—exposed by smoking, solvents etc.
antigen and manifestation: SLE
lupus
nuclear antigens
nephritis, skin lesions, arthritis
antigen and manifestation: poststreptococcal glomerulonephritis
streptococcal cell wall antigen
nephritis
antigen and manifestation: polyarteritis nodosa
Hep B virus antigens (some cases)
Systemic vasculitis
pulmonary arteries are NOT involved
antigen and manifestation: Reactive arthritis
Bacterial antigens
acute arthritis
antigen and manifestation: serum sickness
foreign serum protein
arthritis, vasculitis, nephritis